Literature DB >> 1875416

Glutathione content in human bone marrow and circadian stage relation to DNA synthesis.

R Smaaland1, A M Svardal, K Lote, M Ueland, O D Laerum.   

Abstract

DNA synthesis and contents of reduced glutathione (GSH) and oxidized glutathione were determined every 4 hours during a 24-hour period in 70 human bone marrow samples from 10 healthy males. The mean GSH contents during the sampling periods were low, varying from 1.94 to 3.27 nmol/mg protein between the subjects; the mean values for all samples were 2.54 +/- 0.06 nmol/mg protein. The GSH content varied markedly within the individual according to circadian stage (31.0% to 90.2%; mean, 51.4%). Between individuals the mean percentage of cells in DNA synthesis varied from 10.6% to 14.5%, but there was an intraindividual circadian stage-dependent variation, ranging from 48.9% to 274.0% (mean, 126.6%), relative to the lowest value. After adjustment for a slight phase difference between GSH content and DNA synthesis observed for some of the subjects, a statistically significant correlation was found between the GSH content and the fraction of cells in DNA synthesis. The myelosuppressive effect of many chemotherapeutic agents assumed to be detoxified by GSH-dependent mechanism(s) should be considered in the light of the low GSH content in human bone marrow, the circadian variation of DNA synthesis, and the circadian stage-dependent relationship of the GSH content and DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875416     DOI: 10.1093/jnci/83.15.1092

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  The time of administration of 3'-azido-3'-deoxythymidine (AZT) determines its host toxicity with possible relevance to AZT chemotherapy.

Authors:  R Zhang; Z Lu; C R Diasio; T Liu; S J Soong
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

2.  Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics.

Authors:  P P Brons; C Haanen; J B Boezeman; P Muus; R S Holdrinet; A H Pennings; H M Wessels; T de Witte
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

3.  DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients.

Authors:  R Smaaland; J F Abrahamsen; A M Svardal; K Lote; P M Ueland
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.